OncBioMune Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in the development of novel cancer immunotherapy products, with a proprietary vaccine technology that is designed to stimulate the immune system to attack its own cancer while not hurting the patient. The company is also developing and commercializing specialty drugs in Mexico and other Latin American countries. Its lead product candidate is ProscaVax, which is a prostate cancer vaccine. It has also developed a mouse model to test a whole-cell mouse mammary cancer vaccine.
Baton Rouge, LA, 70809